FDA
-
-
-
-
-
-
-
LB Pharmaceuticals Announces Publication in JAMA Psychiatry of Results from Phase 2 NOVA-1 Trial of LB-102 in Schizophrenia
-
-
-
-
-
-
329,912 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

